临床心身疾病杂志
臨床心身疾病雜誌
림상심신질병잡지
Journal of Clinical Psychosomatic Diseases
2015年
5期
44-46
,共3页
王勇%康明秀%马静%毛稚霞%程娟%窦光茜
王勇%康明秀%馬靜%毛稚霞%程娟%竇光茜
왕용%강명수%마정%모치하%정연%두광천
围绝经期抑郁%心身疾病%度洛西汀%百合地黄汤%中西医结合
圍絕經期抑鬱%心身疾病%度洛西汀%百閤地黃湯%中西醫結閤
위절경기억욱%심신질병%도락서정%백합지황탕%중서의결합
PD%psychosomatic disease%duloxetine%baihe dihuang decoction%combination of Chinese tra-ditional and Western medicine
目的:探讨度洛西汀联合百合地黄汤加减治疗围绝经期抑郁症患者的临床疗效和安全性。方法将60例围绝经期抑郁症患者随机分为两组,均口服度洛西汀肠溶胶囊治疗,研究组在此基础联合百合地黄汤加减治疗,观察8周。于治疗前后采用汉密顿抑郁量表评定抑郁症状,更年期 Kupperman 评分法评估围绝经期躯体症状,副反应量表评定不良反应。结果治疗后两组汉密顿抑郁量表、更年期 Kupperman 评分法评分均较治疗前呈持续性下降,研究组治疗8周末汉密顿抑郁量表及更年期 Kupperman 评分法评分均显著低于对照组(t=2.54、2.28,P<0.05);治疗8周末,观察组显效率为30.0%、总有效率为100%,对照组分别为13.3%、96.7%,两组比较无异著性差异(P>0.05)。两组不良反应均较轻微,研究组不良反应发生率为3.3%,对照组为6.7%,两组比较差异无显著性(χ2=0.35,P>0.05)。结论度洛西汀联合百合地黄汤加减治疗围绝经期抑郁症患者具有协同增效作用,能有效改善患者的抑郁情绪及躯体症状,且不增加不良反应,安全性高。
目的:探討度洛西汀聯閤百閤地黃湯加減治療圍絕經期抑鬱癥患者的臨床療效和安全性。方法將60例圍絕經期抑鬱癥患者隨機分為兩組,均口服度洛西汀腸溶膠囊治療,研究組在此基礎聯閤百閤地黃湯加減治療,觀察8週。于治療前後採用漢密頓抑鬱量錶評定抑鬱癥狀,更年期 Kupperman 評分法評估圍絕經期軀體癥狀,副反應量錶評定不良反應。結果治療後兩組漢密頓抑鬱量錶、更年期 Kupperman 評分法評分均較治療前呈持續性下降,研究組治療8週末漢密頓抑鬱量錶及更年期 Kupperman 評分法評分均顯著低于對照組(t=2.54、2.28,P<0.05);治療8週末,觀察組顯效率為30.0%、總有效率為100%,對照組分彆為13.3%、96.7%,兩組比較無異著性差異(P>0.05)。兩組不良反應均較輕微,研究組不良反應髮生率為3.3%,對照組為6.7%,兩組比較差異無顯著性(χ2=0.35,P>0.05)。結論度洛西汀聯閤百閤地黃湯加減治療圍絕經期抑鬱癥患者具有協同增效作用,能有效改善患者的抑鬱情緒及軀體癥狀,且不增加不良反應,安全性高。
목적:탐토도락서정연합백합지황탕가감치료위절경기억욱증환자적림상료효화안전성。방법장60례위절경기억욱증환자수궤분위량조,균구복도락서정장용효낭치료,연구조재차기출연합백합지황탕가감치료,관찰8주。우치료전후채용한밀돈억욱량표평정억욱증상,경년기 Kupperman 평분법평고위절경기구체증상,부반응량표평정불량반응。결과치료후량조한밀돈억욱량표、경년기 Kupperman 평분법평분균교치료전정지속성하강,연구조치료8주말한밀돈억욱량표급경년기 Kupperman 평분법평분균현저저우대조조(t=2.54、2.28,P<0.05);치료8주말,관찰조현효솔위30.0%、총유효솔위100%,대조조분별위13.3%、96.7%,량조비교무이저성차이(P>0.05)。량조불량반응균교경미,연구조불량반응발생솔위3.3%,대조조위6.7%,량조비교차이무현저성(χ2=0.35,P>0.05)。결론도락서정연합백합지황탕가감치료위절경기억욱증환자구유협동증효작용,능유효개선환자적억욱정서급구체증상,차불증가불량반응,안전성고。
Objective To explore the efficacy and safety of duloxetine plus modified baihe dihuang decoc‐tion in perimenopausal depression (PD ) .Methods Sixty PD patients were randomly divided into two groups taking orally duloxetine capsulae enterosolubilis ,on this basis research group was coupled with modified baihe dihuang decoction for 8 weeks .Deperssive symptoms were assessed with the Hamilton De‐pression Scale (HAMD) before and after treatment ,perimenopausal somatic symptoms with the Kupper‐man Menopausal Index (KMI ) ,and adverse reactions with the Treatment Emergent Symptom Scale (TESS) .Results After treatment the HAMD and KMI scores of both groups lowered continuously com‐pared with pretreatment ,those were significantly lower in research than in control group at the end of the 8th week (t= 2 .54 ,2 .28 ;P< 0 .05) ;at the end of the 8th week obvious and total effective rate were respec‐tively 30 .0% and 100% in research and 13 .3% and 96 .7% in control group ,which showed no significant differences (P> 0 .05) .Adverse reactions of both groups were mild ,their incidences were respectively 3 .3% in research and 6 .7% in control group ,which showed no significant differences (χ2 = 0 .35 ,P >0 .05) .Conclusion Duloxetine coupled with modified baihe dihuang decoction has a synergism in perim‐enopausal depression , could effectively improve patients’ depressive emotions and somatic symptoms , doesn’t increase adverse reactions ,and has higher safety .